🎬 TIBCS Channel is Now Live!

The brand-new TIBCS Channel is officially live!

This year’s TIBCS Channel brings together international experts for in-depth insights into the evolving treatment landscape of HR+/HER2− breast cancer, from precision risk stratification and CDK4/6 inhibitor selection in early breast cancer to ADCs, treatment timing, and sequencing in metastatic disease.

🎙️ Hosts
Dr. Wen-Ying Lin
Dr. Han-Fang Cheng

👨‍⚕️ Featured Experts
Dr. Dejan Juric
Dr. Kim Min-Hwan

Going beyond individual treatment approaches, the interviews connect early and metastatic breast cancer, exploring how advances in treatment may reshape future therapeutic strategies and clinical decision-making.

🔬 Precision Risk Stratification
💊 CDK4/6 Inhibitors
🎯 ADCs & Treatment Sequencing
🌱 From Early to Metastatic Breast Cancer
🚀 The Next 3–5 Years of Innovation

Watch TIBCS Channel now and hear directly from the experts!

Discover the latest perspectives and get a glimpse of what’s next in breast cancer care.